OphthalLogix Intelligence
Subscribe
Sign in
Home
Notes
Archive
About
Latest
Top
Beijing’s IOL Agreement Expired 28 June With No Renewal. Our Q2 2026 Calls, Graded.
The device-renewal rulebook appeared in Q2 for stents, not lenses. A quarter of OphthalLogix judgements graded: what held, what stays untested, and the…
Jul 7
•
OphthalLogix Intelligence
China Healthcare Policy Delta Log — June 2026
One decisive plan, one decisive non-event: a 14-ministry anti-corruption work plan lands, and the first-wave IOL procurement cycle expires with no…
Jul 1
•
OphthalLogix Intelligence
June 2026
Weekly Scan · 15–21 June 2026 · No material signal change
No material policy movement for China's intraocular-lens market in the week of 15–21 June 2026; the end-June procurement-cycle expiry is the item to…
Jun 23
•
OphthalLogix Intelligence
China’s 2026 Anti-Corruption Plan: What 14 Ministries Changed for IOL Market Access
On 8 June 2026, 14 ministries tightened four parts of the medical-device commercial chain at once. For IOL, the most exposed practice is the one that…
Jun 16
•
OphthalLogix Intelligence
Weekly Scan · 1–7 June 2026 · No material signal change
No development this week changed the IOL access, pricing, or payment position. The renewal scheme and the July payment-grouping revision remain the…
Jun 12
•
OphthalLogix Intelligence
In China, Winning the Tender Was Never the Hard Part
China’s national intraocular-lens agreements have begun to lapse with no renewal scheme yet published, but the renewal price is the least interesting…
Jun 10
•
OphthalLogix Intelligence
May 2026 Policy Delta Log: Five Movements, One Convergence
Five regulatory movements in one month: a fund audit reaching ophthalmology, the first procurement cycle turning over, the renewal rulebook hardening…
Jun 8
•
OphthalLogix Intelligence
China’s First IOL Agreements Lapsed at the End of May. The Renewal Playbook Now Exists, Just Not for Lenses.
China's first-wave IOL agreements lapsed end-May 2026 with no renewal scheme, even as the coronary stent renewal set out the device playbook…
Jun 2
•
OphthalLogix Intelligence
May 2026
China’s Coronary Stent Just Set the Template for IOL VBP Renewal, and the IOL Framework Is Still Missing
China’s coronary stent renewal published 13 May 2026. First IOL provincial agreements expire on 30 May. The methodology exists; the IOL instrument does…
May 27
•
OphthalLogix Intelligence
Three compliance signals converged in a single 30-day window in May 2026. The combination is without precedent in China’s IOL market.
Insurance audit targets ophthalmology. IOL procurement agreements expire. NHC surgical standards bind county hospitals. Three compliance signals in one…
May 19
•
OphthalLogix Intelligence
China’s IOL Agreement Expires in 16 Days. No Renewal Framework Has Been Published.
The procurement agreement for China’s national IOL tender ends 30 May. No renewal framework exists. Enterprises are operating without a price floor or a…
May 14
•
OphthalLogix Intelligence
One Month Earlier, Eight Years Later: What China’s 2026 Formulary Consultation Means for Ophthalmology
NHSA advances the 2026 formulary cycle by one month and links commercial insurance to basic formulary eligibility. The anti-VEGF 8-year pricing…
May 12
•
OphthalLogix Intelligence
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
